Key takeaway
Among inpatients who stayed on a ketogenic diet, Hamilton Depression Rating Scale scores fell from 25.4 to 7.7 (P < 0.001) and Montgomery-Åsberg scores from 29.6 to 10.1 (P < 0.001). With no control group, a retrospective design and an unreported number of people excluded for not adhering, the diet cannot be credited with the improvement.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Ketogenic diets help in epilepsy and some neurological conditions, which led the authors to ask whether the same metabolic approach might help severe psychiatric illness. They reviewed what happened when adults whose symptoms stayed poorly controlled despite intensive treatment were placed on a ketogenic diet alongside regular inpatient care.
Who and how
Retrospective analysis of clinical care at a psychiatric hospital. 31 adults with major depressive disorder, bipolar disorder or schizoaffective disorder, and symptoms poorly controlled despite intensive management, were placed on a ketogenic diet limited to a maximum of 20 grams of carbohydrate per day as an addition to usual inpatient care. The duration of the diet ranged from 6 to 248 days. Depression was measured with the Hamilton Depression Rating Scale and the Montgomery-Åsberg Depression Rating Scale, psychosis with the Positive and Negative Syndrome Scale (PANSS), and metabolic measures included weight, blood pressure, blood glucose and triglycerides.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Three patients could not adhere to the diet for more than 14 days and were excluded; the rest were analysed.
- 2Mean (SD) Hamilton Depression Rating Scale scores improved from 25.4 (6.3) to 7.7 (4.2), and Montgomery-Åsberg scores from 29.6 (7.8) to 10.1 (6.5), both P < 0.001.
- 3Among the 10 patients with schizoaffective illness, mean (SD) PANSS scores improved from 91.4 (15.3) to 49.3 (6.9), P < 0.001.
- 4Weight, blood pressure, blood glucose and triglycerides also improved significantly, though the abstract gives no figures for these.
Limits & uncertainty
- 1There was no comparison group, so improvement could stem from hospital care, medication changes, time, or the regular fall of symptoms after admission and not from the diet.
- 2The analysis excluded the 3 people who could not stay on the diet, which makes the diet look easier to follow and more effective than it would across everyone who tried it.
- 3The diet lasted anywhere from 6 to 248 days, so the before-and-after scores compare very different durations, and the abstract does not say when each score was taken.
- 4It was a retrospective review of clinical records in a small inpatient sample, and the abstract does not report side effects in detail.
What to take from it
This report shows that some hospitalized patients were able to follow a strict ketogenic diet under supervision, and that their scores improved. It does not show that the diet treats depression, bipolar disorder or schizoaffective illness. Anyone with severe mental illness should not change diet or medication without their psychiatrist, since both can affect each other.
Reading your own data
Home glucose or ketone readings, weight, blood pressure cuff readings and a food log could show how a diet changes metabolic markers, but they do not measure mental health. Use the same device and time of day, and review trends with your clinician.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background and hypothesis
The robust evidence base supporting the therapeutic benefit of ketogenic diets in epilepsy and other neurological conditions suggests this same metabolic approach may also benefit psychiatric conditions.
Study design
In this retrospective analysis of clinical care, 31 adults with severe, persistent mental illness (major depressive disorder, bipolar disorder, and schizoaffective disorder) whose symptoms were poorly controlled despite intensive psychiatric management were admitted to a psychiatric hospital and placed on a ketogenic diet restricted to a maximum of 20 grams of carbohydrate per day as an adjunct to conventional inpatient care. The duration of the intervention ranged from 6 to 248 days.
Study results
Three patients were unable to adhere to the diet for >14 days and were excluded from the final analysis. Among included participants, means and standard deviations (SDs) improved for the Hamilton Depression Rating Scale scores from 25.4 (6.3) to 7.7 (4.2), P < 0.001 and the Montgomery-Åsberg Depression Rating Scale from 29.6 (7.8) to 10.1 (6.5), P < 0.001. Among the 10 patients with schizoaffective illness, mean (SD) of the Positive and Negative Syndrome Scale (PANSS) scores improved from 91.4 (15.3) to 49.3 (6.9), P < 0.001. Significant improvements were also observed in metabolic health measures including weight, blood pressure, blood glucose, and triglycerides.
Conclusions
The administration of a ketogenic diet in this semi-controlled setting to patients with treatment-refractory mental illness was feasible, well-tolerated, and associated with significant and substantial improvements in depression and psychosis symptoms and multiple markers of metabolic health.
Sources & attribution
The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients.
Danan A, Westman EC, Saslow LR, Ede G.
Frontiers in psychiatry · 2022-07-06
DOI: 10.3389/fpsyt.2022.951376 ↗PubMed · 35873236 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

